- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05449002
Digital Single Session Intervention for Youth Mental Health
Testing a Digital Single-session Intervention for Youths on the Waitlist for Psychotherapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is a massive unmet need for youth mental health care in America; only ¼ of youth in need receive services. The problem has been underscored and exacerbated by the pandemic. The need for child and adolescent mental health care, particularly for depression and anxiety, has surged while clinician availability and clinic funding have shrunk. One result is that clinic waitlists, always lengthy, have stretched, with youths and families who seek care waiting for up to 12 months for a first appointment, and many giving up and dropping out before the much-delayed appointment. There is a clear need-in both pandemic and normal times-for efficient mental health support that can be provided when need is acute, to sustain young people through periods of delayed access, and to reduce burden for professionals. Fortunately, recent evidence shows the surprising potential of brief, low-cost, digital interventions that could go a long way toward bridging the need-to-access gap. Single-session interventions have substantial effects, in some cases rivaling effects of full-length in-person psychotherapy. Remote therapies for youth mental health problems are beneficial on average and approximately as beneficial as in-person psychotherapy.
The current trial will test a brief (one 30-45-minute session), online, interactive mental health and behavior change intervention for adolescents (9-17 years old), who have been placed the waitlist for outpatient treatment at participating mental health clinics in the United States. Previous RCTs show beneficial effects of the principle of Practicing the Opposite (PTO) on youth mental health when using the therapeutic elements present in PTO (e.g., exposure, to overcome anxiety; behavioral activation, to overcome depression). The single-session PTO intervention uses stories, interactive activities, and engaging graphics to teach youths a key principle: by practicing the positive opposite of unhelpful behaviors, one can, over time, change their emotions thoughts, and actions.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Recruiting
- Riley Child Psychiatry and Behavioral Sciences Clinic
-
Contact:
- Gabriella Rodríguez, PhD, HSPP
- Phone Number: 317-944-8162
- Email: gabrodri@iu.edu
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02116
- Recruiting
- Boston Child Study Center
-
Contact:
- Ashley Flynn
- Phone Number: 617-800-9610
- Email: aflynn@bostonchildstudycenter.com
-
Boston, Massachusetts, United States, 02120
- Recruiting
- The Baker Center for Children and Families
-
Contact:
- Sarah Tannenbaum, PsyD, ABPP
- Phone Number: 617-278-4252
- Email: stannenbaum@bakercenter.org
-
Concord, Massachusetts, United States, 01742
- Recruiting
- The Concord Center
-
Contact:
- Jamie Micco, PhD
- Phone Number: 978-405-2544
- Email: jmicco@concordcbt.com
-
Dedham, Massachusetts, United States, 02026
- Active, not recruiting
- Riverside Community Care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Youth/family has contacted a participating outpatient clinic to seek mental health care, and is placed on the waitlist.
- Youth is between the ages of 9-17 years (inclusive) at the time of study enrollment.
- Youth and at least one guardian consent to the youth's participation in study.
- Youth reads English well enough to effectively complete the digital programs (defined as taking classes in English, as opposed to ESL classes).
- Youth has access to a digital device.
Exclusion Criteria:
- Youth is non-English speaking, as the program is only available in English.
- Youth does not have access to a digital device.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Practicing the Opposite (PTO) intervention
This 30-45 minutes Qualtrics-based, digital program uses stories, interactive activities, and engaging graphics to teach youths one core principle: by practicing the positive opposite of unhelpful behaviors (e.g., engaging with rather than avoiding feared stimuli), one can, over time, change their mood, thoughts, and actions.
The intervention is comprised of four main sections: 1) An introduction to PTO; (2) Testimonials from young people who have been helped by PTO; (3) Learning how to Practice the Opposite through online activities.
(4) Planning how to continue to Practice the Opposite in the participant's life.
Of note, after being removed from the waitlist at the clinic and contacted to begin treatment, participants will still receive treatment as usual from the clinic.
|
This 30-45-minute digital program is designed to help youths on the waitlist feel better prior to treatment and may also improve their treatment engagement and outcomes.
|
Other: Usual waitlist control group
Usual waitlist procedures involve watchful waiting for a therapist to become available, sometimes complemented by periodic check-ins from the family with clinic administrators.
After being removed from the waitlist and contacted to begin treatment, participants in both study conditions will receive treatment as usual in the clinic.
|
Usual care provided by participating youth mental health clinics in the United States.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavior and Feelings Survey (Youth and Parent Versions)
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Assesses the child's thoughts and feelings over the past week using both youth and parent report.
Both the youth and parent report surveys include 12 items each scored from 04, with higher scores indicating more severe symptoms.
Consists of an internalizing and externalizing subscale, the trajectories of which will be analyzed separately and compared between the intervention and control group.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Generalized Anxiety Disorder 7-item scale (GAD-7)
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Assesses via a 7-item youth self-report questionnaire (in which scores range from 0-21, and higher scores indicate more severe symptoms) the youth's experience of anxiety symptoms.
Trajectory of change on this measure will be compared between the intervention and control group.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Patient Health Questionnaire 8-item scale (PHQ-8)
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Assesses via an 8-item youth self-report questionnaire (in which scores range from 0-24, and higher scores indicate more severe symptoms) the youth's experience of anxiety symptoms.
Trajectory of change on this measure will be compared between the intervention and control group.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Revised Children's Anxiety and Depression Scale (RCADS) Parent Version (Short Form)
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Trajectory of change on this 24-item parent-report measure of anxiety and depression (in which scores range from 0-72 and higher scores indicate more severe symptoms) will be compared between the intervention and control group.
Trajectories of change on the subscales within this measure (broad anxiety and depression) may also be analyzed similarly.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and monthly follow-up until completion of clinic treatment or 1 year, whichever comes first.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ecological Momentary Assessment (EMA) Survey
Time Frame: Scores on each item will be compared across 1 week before the PTO intervention and 2-weeks after. The association between change in behaviors and change in affect across these time ranges will be assessed.
|
Consisting of a modified Positive and Negative Affect Scale (PANAS) and a modified Coping Questionnaire, this 8-item measure is administered 3 times daily via an EMA mobile application called Metricwire.
It assesses affect and behaviors via youth self-report.
|
Scores on each item will be compared across 1 week before the PTO intervention and 2-weeks after. The association between change in behaviors and change in affect across these time ranges will be assessed.
|
State Hope Scale
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and 1-month follow-up.
|
Assesses the child's current level of hope using a six-item self-report scale, in which each item is scored from 1 to 8, with higher scores indicating greater hope.
Trajectory of change on this measure will be compared between the intervention and control group.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and 1-month follow-up.
|
Perceived Control Scale for Children
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and 1-month follow-up.
|
Assesses via a 24-item self-report scale the youth's beliefs about their ability to control and change their environment.
Total scores range from 0-72, with higher scores indicating greater perceived control.
Trajectory of change on this measure will be compared between the intervention and control group.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and 1-month follow-up.
|
Secondary Control Scale for Children
Time Frame: Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and 1-month follow-up.
|
Assesses via a 20-item self-report scale the youth's beliefs about their ability to control and change their emotions and thoughts.
Total scores range from 0-60, with higher scores indicating greater secondary control.
Trajectory of change on this measure will be compared between the intervention and control group.
Note that timing described below may be adjusted if response or feedback suggests excessive measurement burden.
|
Trajectory of change in scores compared across intervention and control groups from baseline, through post-intervention, 2-week, and 1-month follow-up.
|
Clinic Record Data
Time Frame: Through study completion, an anticipated average of 6-months
|
For those participants who authorize investigator access to their clinic record data, the investigators will also compare rates of accessing and completing clinic treatment, as well as attendance at sessions, between the intervention and control groups.
|
Through study completion, an anticipated average of 6-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feedback Questionnaire
Time Frame: immediately post-intervention
|
Elicits feedback from the youth about the digital practicing the opposite program.
|
immediately post-intervention
|
Demographic Questionnaire
Time Frame: pre-intervention
|
Asks caregiver and youth for basic youth and family demographic information.
|
pre-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Katherine Venturo-Conerly, A.B., Harvard University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB22-0101
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Practicing the Opposite (PTO)
-
Matthew SouthwardNational Institute of Mental Health (NIMH)RecruitingDepression | Obsessive-Compulsive Disorder | Anxiety | Borderline Personality Disorder | Posttraumatic Stress Disorder | Eating Disorders | Emotional RegulationUnited States
-
Istituto Nazionale di Ricovero e Cura per AnzianiEuropean UnionRecruitingMild Cognitive Impairment | Older AdultsItaly, Norway, Switzerland
-
Federal University of BahiaCompletedCommunity-acquired PneumoniaBrazil
-
Zeynep YurdakulUnknown